In just a few years, what began as a scientific project—to use AI models for generating images—has become an everyday application. Along with this development, new problems have emerged. Increasingly, ...

Developing new biomarker assays is highly specialised work. It requires careful screening of antibody pairs, sensitivity and specificity testing, and performance validation across different sample ...

Learn effective batch record review with our accredited training. Understand Master Batch Records, regulatory requirements, and best practices in pharmaceutical, biologic, and medical device ...

As the EU launches its €1 billion Innovation Fund to decarbonize industrial heat, Brenmiller enters as a proven, ...

Pradeep Kumar's work stands as a technical counterbalance: one that demands rigor, rewards realism, and quietly keeps the ...

Researchers from Denmark and the United States have developed a powerful new artificial intelligence system that can predict events in people’s lives—including estimating when someone might die. This ...

This article is this edition's winner of the ASU Writing Competition. The competition is open quarterly to current ASU ...

This precision medicine approach, driven by granular, real-world evidence, is critical for reshaping clinical guidelines and ...

Harfang Exploration Inc. (TSX.V: HAR) (“Harfang” or the “Company”) announces exploration plans for its portfolio of wholly-owned gold and critical and strategic mineral ...

EFA offers developed market exposure but suffers from weak growth drivers and redundancy versus U.S. stocks, limiting appeal.

U.S. Sanger Sequencing Market to Hit USD 4.25 Billion by 2032 as Demand for Reliable Genetic Sequencing in Healthcare Intensifies.Austin, July 16, 2025 (GLOBE NEWSWIRE) -- Sanger Sequencing Market ...

Opinion: Sullivan & Cromwell attorneys Frank Aquila and Catherine Yuh say firms that don't take advantage of AI to identify M&A targets will be left behind by competitors.